UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

517 Identification and characterization of selective MELK kinase inhibitors

European journal of cancer (1990), 2014-11, Vol.50, p.168-168

2014

Volltextzugriff (PDF)

31 N-Myc amplification sensitizes tumor cells to inhibition by Danusertib, an Aurora kinase inhibitor

European journal of cancer (1990), 2014-11, Vol.50, p.16-16

2014

Volltextzugriff (PDF)

Abstract P3-06-05: Not presented

Cancer research (Chicago, Ill.), 2018-02, Vol.78 (4_Supplement), p.P3-P3-06-05

2018

Volltextzugriff (PDF)

136 Activity of the Cdc7 inhibitor NMS-1116354 as single agent and in combination in breast cancer models

European journal of cancer supplements, 2010, Vol.8 (7), p.49-49

2010

Volltextzugriff (PDF)

102 Identification and preclinical characterization of NMS-P626, a potent, selective and orally bioavailable TrkA inhibitor with anti-tumor activity in a TrkA-dependent colorectal cancer

European journal of cancer supplements, 2010, Vol.8 (7), p.39-40

2010

Volltextzugriff (PDF)

Catecholic Flavonoids Acting as Telomerase Inhibitors

Journal of medicinal chemistry, 2004-12, Vol.47 (26), p.6466-6475

2004

Volltextzugriff (PDF)

Delivery of methoxymorpholinyl doxorubicin by interleukin 2-activated NK cells: effect in mice bearing hepatic metastases

British journal of cancer, 1999-03, Vol.79 (7-8), p.1067-1073

1999

Volltextzugriff (PDF)

Biological profile of FCE 24517, a novel benzoyl mustard analogue of distamycin A

British journal of cancer, 1991-12, Vol.64 (6), p.1047-1050

1991

Volltextzugriff (PDF)

Pharmacology and Clinical Toxicity of 4′-Iodo-4′-deoxydoxorubicin: An Example of Successful Application of Pharmacokinetics to Dose Escalation in Phase I Trials

JNCI : Journal of the National Cancer Institute, 1990-03, Vol.82 (6), p.469-477

1990

Volltextzugriff (PDF)

Uncoupling Signal Transducers from Oncogenic MET Mutants Abrogates Cell Transformation and Inhibits Invasive Growth

Proceedings of the National Academy of Sciences - PNAS, 1998-11, Vol.95 (24), p.14379-14383

1998

Volltextzugriff (PDF)

Interaction of the Anthracycline 4'-Iodo-4'-Deoxydoxorubicin with Amyloid Fibrils: Inhibition of Amyloidogenesis

Proceedings of the National Academy of Sciences - PNAS, 1995-03, Vol.92 (7), p.2959-2963

1995

Volltextzugriff (PDF)

4′-Iodo-4′-Deoxydoxorubicin Disrupts the Fibrillar Structure of Transthyretin Amyloid

The American journal of pathology, 2000-06, Vol.156 (6), p.1919-1925

2000

Volltextzugriff (PDF)

Phase I/II trial of nemorubicin hydrochloride in combination with cisplatin is supported by new preclinical evidences of its mechanism of action

Journal of clinical oncology, 2006-06, Vol.24 (18_suppl), p.14116-14116

2006

Volltextzugriff (PDF)

In vitro cell growth pharmacodynamic studies: a new nonparametric approach to determining the relative importance of drug concentration and treatment time

Cancer chemotherapy and pharmacology, 2003-12, Vol.52 (6), p.507-513

2003

Volltextzugriff (PDF)

304 POSTER Combination treatment of new molecular-targeted therapies and the DNA minor groove binder brostallicin

European journal of cancer supplements, 2006-11, Vol.4 (12), p.95-96

2006

Volltextzugriff (PDF)

Selective DNA interaction of the novel distamycin derivative FCE 24517

Cancer research (Chicago, Ill.), 1991, Vol.51 (1), p.199-204

1991

Volltextzugriff (PDF)

Early lymphocyte activation molecule defined by the monoclonal antibody MLR-3: biochemical and functional studies

Immunology, 1988-08, Vol.64 (4), p.593-598

1988

Volltextzugriff (PDF)

Characterization of papillomavirus polypeptides from bovine cutaneous fibropapillomas

Journal of general virology, 1988-11, Vol.69 (11), p.2919-2924

1988

Volltextzugriff (PDF)

471 In vitro and in vivo antitumor activity of nemorubicin metabolites

European journal of cancer supplements, 2004-09, Vol.2 (8), p.144-144

2004

Volltextzugriff (PDF)

Signal transducers as molecular targets for cancer therapy

European journal of cancer (1990), 1997-09, Vol.33, p.S143-S143

1997

Volltextzugriff (PDF)

Tumor-associated alien alloantigens of BALB/c tumors encoded by the MHC and by non-H-2 genes: a histogenetic study

The Journal of immunology (1950), 1980-02, Vol.124 (2), p.662-668

1980

Volltextzugriff (PDF)

Modulation of multidrug resistance by verapamil or mdr1 anti‐sense oligodeoxynucleotide does not change the high susceptibility to lymphokine‐activated killers in mdr‐resistant human carcinoma (LoVo) line

International journal of cancer, 1990-10, Vol.46 (4), p.727-732

1990

Volltextzugriff (PDF)

Expression of H-2 and Viral Antigens and Resistance to the Antitumor Lysis of Tunicamycin-treated MBL-2 Lymphoma Cells

Immunobiology (1979), 1983-08, Vol.165 (2), p.186-199

1983

Volltextzugriff (PDF)

Biochemical characterization of the anomalous reaction of anti-H-2b alloantiserum with a chemically induced sarcoma of H-2k origin

Transplantation proceedings, 1981-12, Vol.13 (4), p.1774

1981

Volltextzugriff (PDF)

Role of the carbohydrate prosthetic groups in the biosynthesis of membrane antigens and in the H-2-restricted lysis of MBL-2 lymphoma cells

Transplantation proceedings, 1983-01, Vol.15 (4), p.2068-2073

1983

Volltextzugriff (PDF)

1 – 25 von 68

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(60)
Mit Volltextzugriff
(58)

Publikationsform

Artikel
(68)

Sprache

Englisch
(66)
Italienisch
(2)

Erscheinungsjahr

n.n

Thema

Science & Technology
(32)
Life Sciences & Biomedicine
(30)
Animals
(28)
Mice
(24)
Biological And Medical Sciences
(20)
Humans
(17)
Medical Sciences
(15)
Oncology
(15)
Antineoplastic Agents
(12)
Pharmacology. Drug Treatments
(12)
Female
(9)
Mice, Inbred Balb C
(9)
Immunology
(8)
Doxorubicin - Analogs & Derivatives
(7)
Fibrosarcoma - Immunology
(6)
Chemotherapy
(5)
Doxorubicin - Pharmacology
(5)
Fundamental And Applied Biological Sciences. Psychology
(5)
Lymphoma - Immunology
(5)
Mice, Inbred Strains
(5)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

517 Identification and characterization of selective MELK kinase inhibitors

31 N-Myc amplification sensitizes tumor cells to inhibition by Danusertib, an Aurora kinase inhibitor

Abstract P3-06-05: Not presented

136 Activity of the Cdc7 inhibitor NMS-1116354 as single agent and in combination in breast cancer models

102 Identification and preclinical characterization of NMS-P626, a potent, selective and orally bioavailable TrkA inhibitor with anti-tumor activity in a TrkA-dependent colorectal cancer

Catecholic Flavonoids Acting as Telomerase Inhibitors

Delivery of methoxymorpholinyl doxorubicin by interleukin 2-activated NK cells: effect in mice bearing hepatic metastases

Biological profile of FCE 24517, a novel benzoyl mustard analogue of distamycin A

Pharmacology and Clinical Toxicity of 4′-Iodo-4′-deoxydoxorubicin: An Example of Successful Application of Pharmacokinetics to Dose Escalation in Phase I Trials

Uncoupling Signal Transducers from Oncogenic MET Mutants Abrogates Cell Transformation and Inhibits Invasive Growth

Interaction of the Anthracycline 4'-Iodo-4'-Deoxydoxorubicin with Amyloid Fibrils: Inhibition of Amyloidogenesis

4′-Iodo-4′-Deoxydoxorubicin Disrupts the Fibrillar Structure of Transthyretin Amyloid

Phase I/II trial of nemorubicin hydrochloride in combination with cisplatin is supported by new preclinical evidences of its mechanism of action

In vitro cell growth pharmacodynamic studies: a new nonparametric approach to determining the relative importance of drug concentration and treatment time

304 POSTER Combination treatment of new molecular-targeted therapies and the DNA minor groove binder brostallicin

Selective DNA interaction of the novel distamycin derivative FCE 24517

Early lymphocyte activation molecule defined by the monoclonal antibody MLR-3: biochemical and functional studies

Characterization of papillomavirus polypeptides from bovine cutaneous fibropapillomas

471 In vitro and in vivo antitumor activity of nemorubicin metabolites

Signal transducers as molecular targets for cancer therapy

Tumor-associated alien alloantigens of BALB/c tumors encoded by the MHC and by non-H-2 genes: a histogenetic study

Modulation of multidrug resistance by verapamil or mdr1 anti‐sense oligodeoxynucleotide does not change the high susceptibility to lymphokine‐activated killers in mdr‐resistant human carcinoma (LoVo) line

Expression of H-2 and Viral Antigens and Resistance to the Antitumor Lysis of Tunicamycin-treated MBL-2 Lymphoma Cells

Biochemical characterization of the anomalous reaction of anti-H-2b alloantiserum with a chemically induced sarcoma of H-2k origin

Role of the carbohydrate prosthetic groups in the biosynthesis of membrane antigens and in the H-2-restricted lysis of MBL-2 lymphoma cells

Suchergebnisse filtern